ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

Rover Group Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	32,684	30,329	61,371	72,957	116,484	154,280
Market Cap Growth	-45.87%	-50.58%	-15.88%	-37.37%	-24.50%	44.17%
Enterprise Value	53,000	46,301	72,291	79,771	118,025	152,660
Last Close Price	1055.00	979.00	1981.00	2355.00	3760.00	4980.00
PE Ratio	-	-	-	130.12	-	-
PS Ratio	0.53	0.48	0.98	1.06	2.02	2.36
PB Ratio	1.24	1.06	1.58	1.42	2.41	2.72
P/TBV Ratio	1.15	0.99	1.53	1.40	2.37	2.68
P/OCF Ratio	-	-	-	-	-	80.28
EV/Sales Ratio	0.86	0.74	1.15	1.16	2.05	2.34
EV/EBITDA Ratio	-	-	-	41.85	-	127.84
EV/FCF Ratio	-9.15	-	-	-	-	-
Debt / Equity Ratio	0.95	0.86	0.45	0.36	0.34	0.18
Debt / EBITDA Ratio	-	-	-	9.80	-	8.58
Asset Turnover	0.86	0.86	0.79	0.83	0.71	0.77
Inventory Turnover	3.07	3.26	3.28	4.03	3.26	3.59
Quick Ratio	0.64	0.70	0.93	1.24	1.38	1.70
Current Ratio	1.05	1.08	1.45	1.76	1.92	2.47
Return on Equity (ROE)	-33.75%	-30.21%	-24.69%	1.03%	-15.30%	-2.96%
Return on Assets (ROA)	-8.89%	-8.44%	-6.87%	-0.36%	-5.37%	-1.37%
Return on Capital (ROIC)	-11.46%	-11.22%	-8.70%	-0.45%	-6.64%	-1.70%
Earnings Yield	-30.99%	-31.67%	-17.13%	0.77%	-6.91%	-0.85%
FCF Yield	-17.73%	-16.55%	-3.76%	-5.79%	-4.31%	-1.09%
Buyback Yield / Dilution	-0.71%	-	-	-	-	-9.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.